vs
FULTON FINANCIAL CORP（FULT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是FULTON FINANCIAL CORP的1.9倍（$622.0M vs $336.2M），Royalty Pharma plc净利率更高（34.4% vs 28.2%，领先6.2%），Royalty Pharma plc同比增速更快（4.8% vs 4.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 0.2%）
富尔顿金融公司是美国的区域性金融服务控股企业，总部位于宾夕法尼亚州兰开斯特市，主要为当地及周边区域提供多元化的金融相关服务，在区域金融市场拥有稳定的业务布局。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FULT vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$336.2M
营收增速更快
RPRX
高出0.6%
4.2%
净利率更高
RPRX
高出6.2%
28.2%
两年增速更快
RPRX
近两年复合增速
0.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $336.2M | $622.0M |
| 净利润 | $94.8M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 28.2% | 34.4% |
| 营收同比 | 4.2% | 4.8% |
| 净利润同比 | 1.9% | 2.9% |
| 每股收益（稀释后） | $0.55 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FULTRPRX
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | $622.0M | ||
| Q3 25 | $334.6M | $609.3M | ||
| Q2 25 | $324.1M | $578.7M | ||
| Q1 25 | $318.4M | $568.2M | ||
| Q4 24 | $319.6M | $593.6M | ||
| Q3 24 | $317.7M | $564.7M | ||
| Q2 24 | $334.7M | $537.3M |
净利润FULTRPRX
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | $214.2M | ||
| Q3 25 | $100.5M | $288.2M | ||
| Q2 25 | $99.2M | $30.2M | ||
| Q1 25 | $93.0M | $238.3M | ||
| Q4 24 | $68.6M | $208.2M | ||
| Q3 24 | $63.2M | $544.0M | ||
| Q2 24 | $95.0M | $102.0M |
营业利润率FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | 62.4% | ||
| Q3 25 | 38.2% | 70.1% | ||
| Q2 25 | 37.8% | 36.3% | ||
| Q1 25 | 36.1% | 94.0% | ||
| Q4 24 | 27.0% | 60.9% | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 30.8% | 50.2% |
净利率FULTRPRX
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | 34.4% | ||
| Q3 25 | 30.0% | 47.3% | ||
| Q2 25 | 30.6% | 5.2% | ||
| Q1 25 | 29.2% | 41.9% | ||
| Q4 24 | 21.5% | 35.1% | ||
| Q3 24 | 19.9% | 96.3% | ||
| Q2 24 | 28.4% | 19.0% |
每股收益（稀释后）FULTRPRX
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | $0.49 | ||
| Q3 25 | $0.53 | $0.67 | ||
| Q2 25 | $0.53 | $0.07 | ||
| Q1 25 | $0.49 | $0.55 | ||
| Q4 24 | $0.36 | $0.46 | ||
| Q3 24 | $0.33 | $1.21 | ||
| Q2 24 | $0.52 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.5B | $9.7B |
| 总资产 | $32.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益FULTRPRX
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $9.7B | ||
| Q3 25 | $3.4B | $9.6B | ||
| Q2 25 | $3.3B | $9.5B | ||
| Q1 25 | $3.3B | $9.8B | ||
| Q4 24 | $3.2B | $10.3B | ||
| Q3 24 | $3.2B | $10.3B | ||
| Q2 24 | $3.1B | $9.8B |
总资产FULTRPRX
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | $19.6B | ||
| Q3 25 | $32.0B | $19.3B | ||
| Q2 25 | $32.0B | $18.3B | ||
| Q1 25 | $32.1B | $17.6B | ||
| Q4 24 | $32.1B | $18.2B | ||
| Q3 24 | $32.2B | $18.0B | ||
| Q2 24 | $31.8B | $17.7B |
负债/权益比FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | $827.1M | ||
| Q3 25 | $116.1M | $702.6M | ||
| Q2 25 | $91.7M | $364.0M | ||
| Q1 25 | $703.0K | $596.1M | ||
| Q4 24 | $416.6M | $742.5M | ||
| Q3 24 | $-22.0M | $703.6M | ||
| Q2 24 | $157.8M | $658.2M |
现金转化率FULTRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 3.86× | ||
| Q3 25 | 1.16× | 2.44× | ||
| Q2 25 | 0.92× | 12.06× | ||
| Q1 25 | 0.01× | 2.50× | ||
| Q4 24 | 6.07× | 3.57× | ||
| Q3 24 | -0.35× | 1.29× | ||
| Q2 24 | 1.66× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FULT
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
